DCGI Grants Permission For New Eye Drug Trial

by Shirley Johanna on  June 24, 2016 at 8:14 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The Drug Controller General of India (DCGI) has given its nod to biopharmaceutical firm Biocon and its Israeli partner Quark Pharmaceuticals to proceed with human clinical trials for a new drug candidate, 'QPI-1007' targeting orphan eye disease.
DCGI Grants Permission For New Eye Drug Trial
DCGI Grants Permission For New Eye Drug Trial

Orphan eye disease is a condition that affects fewer than 200,000 people nationwide.

The study will determine the effect of QPI-1007 on visual function in subjects with acute non-arteritic ischemic optic neuropathy (NAION), a rare ocular disorder with an unmet need globally.

Both the companies have also received approval to proceed with the study, the first ever clinical trial of a siRNA (small interfering RNA) therapy in India.

Biocon CMD Kiran Mazumdar-Shaw said, "India has a significant NAION patient population. We are the first biopharma company in the country to provide an siRNA-based therapy that is likely to benefit thousands of patients who either have no access to treatment or cannot afford it."

Biocon and Quark Pharmaceuticals also announced the randomization of the first patient in India in the global Phase II/III study of the new drug candidate, the company said in a statement.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Nervous Tic Signature Drug Toxicity Eye Vision LASIK Surgery Facts Allergy Eye Drops 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive